Virtu Financial’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.09M Buy
+7,555
New +$4.25M 0.13% 81
2025
Q4
Sell
-6,590
Closed -$2.76M 2272
2025
Q3
$2.76M Buy
6,590
+1,724
+35% +$580K 0.15% 128
2025
Q2
$1.4M Buy
+4,866
New +$1.45M 0.07% 247
2024
Q2
Sell
-1,530
Closed -$351K 1907
2024
Q1
$351K Sell
1,530
-4,625
-75% -$1.04M 0.03% 552
2023
Q4
$1.35M Buy
+6,155
New +$1.42M 0.11% 160
2021
Q2
Sell
-2,584
Closed -$432K 2098
2021
Q1
$432K Buy
+2,584
New +$431K 0.03% 600
2020
Q4
Sell
-2,593
Closed -$262K 1820
2020
Q3
$262K Buy
+2,593
New +$285K 0.04% 500
2019
Q4
$506K Sell
5,750
-848
-13% -$74.6K 0.05% 420
2019
Q3
$526K Buy
6,598
+3,820
+138% +$308K 0.04% 493
2019
Q2
$217K Sell
2,778
-1,871
-40% -$175K 0.01% 986
2019
Q1
$546K Buy
+4,649
New +$542K 0.03% 519
2017
Q4
Sell
-10,914
Closed -$1.28M 3043
2017
Q3
$1.28M Buy
+10,914
New +$1.39M 0.06% 334
2015
Q3
Sell
-2,295
Closed -$399K 401
2015
Q2
$399K Buy
+2,295
New +$413K 0.04% 233
2014
Q4
Sell
-2,066
Closed -$266K 395
2014
Q3
$266K Buy
+2,066
New +$213K 0.03% 238

Other funds holding UTHR

Virtu Financial's UTHR Position: Q2 2026 in Review

Virtu Financial opened a new position in United Therapeutics (UTHR) in Q2 2026: 7,555 shares worth $4.09M. The stake represents 0.13% of the portfolio and ranks #81 among its holdings. This is a return to the name: Virtu Financial previously reported a position in UTHR as recently as Q3 2025.

Virtu Financial first reported a position in UTHR in Q3 2014 and has held it in 14 quarters since. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Virtu Financial held 7,555 shares of United Therapeutics worth $4.09M as of Q2 2026.
  • United Therapeutics was a new Virtu Financial position in Q2 2026.
  • United Therapeutics made up 0.13% of Virtu Financial's portfolio in Q2 2026, its #81 holding.
  • Virtu Financial first reported a position in United Therapeutics in Q3 2014 and has held it in 14 quarters since.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.